𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients

✍ Scribed by R.L. Brady; K. Green; C. Frei; P. Maxwell

Book ID
110904268
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
121 KB
Volume
11
Category
Article
ISSN
1398-2273

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased incidence of cytomegalovirus i
Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis
✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

Valganciclovir for cytomegalovirus proph
Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients
✍ Jeong M. Park; Kathleen D. Lake; Robert J. Fontana πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 48 KB

We thank Jain et al. for their interest and correspondence regarding our recently published study. 1 The authors note that the incidence of cytomegalovirus (CMV) disease in our retrospective study was much lower than that reported by others. As acknowledged in our article, we did not use routine sur